Treatment with omega-3 PUFA resulted in reduction of Lp-PLA2 mass by 10.7 % , activity by 9.3 ( p = 0.026 for both ) and oxy-LDL by 10.9 % ( p = 0.014 ) at 30 days , with no change in myeloperoxidase and interleukin-6 .